stocktools
Dilution profile // every instrument, one screen, from SEC filings

ClearPoint Neuro, Inc. (CLPT)

CIK 1285550 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (overhead supply)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
MEDIUM$19.9M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
HIGHwarrants = 68% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+24% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
MEDIUM~14.7 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-11-102026-07-27

Latest: 30.5M shares as of Jul 27, 2026 (10-Q). Share count fell from 95.9M to 2.4M between Apr 14, 2016 and Aug 1, 2016, a pattern consistent with a reverse split (roughly 1-for-40); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 20.8M underlying shares, as reported Mar 31, 2015 (10-Q).

Reported exercise price: $1300000 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $4.1M as of Sep 30, 2013.

Rough fully diluted estimate: 51.3M = 30.5M O/S + 20.8M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 3, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding30.5MJul 27, 2026
+ Warrants (aggregate, as tagged) (if exercised)20.8MMar 31, 2015
Fully diluted estimate51.3M+68.1% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $19.9Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3Jan 14, 2026$19.9M registeredfiling →
S-3Nov 9, 2023no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 1 executed · 1 registered.

UPDATEJan 22, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEJan 22, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJan 14, 2026S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDNov 20, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDMay 12, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDNov 7, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDMar 1, 2024Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →
EXECUTEDFeb 28, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EFFECTIVENov 20, 2023SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDNov 9, 2023S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDFeb 19, 2021Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDFeb 18, 2021Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full CLPT workspace